WithdrawnNot Applicable

Common Factors Group Psychotherapy for General Mental Health Concerns

Stopped: Inability for consistent recruitment.

0Started 2025-01-17

Plain-language summary

The current research will investigate the impact of general psychotherapy using common factors (i.e., techniques and communication skills that are common to all major forms of psychotherapy) to investigate whether mental health professionals can treat a variety of mental health concerns utilizing this general form of psychotherapy as opposed to specific forms of psychotherapy that may require specific trainings or education.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * At least 18 years old * Experiencing self-reported psychological distress Exclusion Criteria: * has engaged in self-harm within the last three months * has attempted suicide within the last year * has had an active plan to attempt suicide within the last 30 days * currently diagnosed with any eating disorder * has experienced hallucinations or delusions within the last 30 days * has used narcotics within the last 7 days (heroin, meth, crack cocaine, opioids)

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1This trial's status is listed as 'withdrawn,' which means it never enrolled participants — can you help me understand what that means for my options, and whether a similar group psychotherapy study is available elsewhere?
2The trial was testing a 'common factors' approach to group therapy for conditions like depression, generalized anxiety, PTSD, and OCD all together — is that kind of broad, unified therapy approach something that might actually fit my specific diagnosis, or would a more targeted treatment make more sense for me?
3The study was planning to measure outcomes using screening tools like the PHQ-9 for depression and the GAD-7 for anxiety — are those the same tools you're already using to track how I'm doing, and what do my current scores suggest about where I should start with treatment?
4Since this trial never got off the ground, is there any published evidence you're aware of that supports common factors group psychotherapy for someone with my combination of symptoms, so I can understand whether this approach has real promise?
5Given that this trial was withdrawn before enrolling anyone, would you recommend I look into standard individual therapy or medication options first, rather than waiting for a group psychotherapy research study to become available?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Generalized Anxiety Disorder-7 Screener

Timeframe: At enrollment and at the end of treatment at 6 weeks

Patient Health Questionnaire-9 Screener

Timeframe: At enrollment and at the end of treatment at 6 weeks

Patient Checklist-5

Timeframe: At enrollment and at the end of treatment at 6 weeks

Yale-Brown Obsessive Compulsive Scale

Timeframe: At enrollment and at the end of treatment at 6 weeks

Alcohol Use Disorders Identification Test

Timeframe: At enrollment and at the end of treatment at 6 weeks

National Institute of Drug Abuse Modified Alcohol, Smoking, and Substance Involvement Screening Test

Timeframe: At enrollment and at the end of treatment at 6 weeks

Trial details

NCT IDNCT06614842

SponsorUniversity of Alabama at Birmingham

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-12-30

View on ClinicalTrials.gov More Major Depression trials

Plain-language summary

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Generalized Anxiety Disorder-7 Screener

Timeframe: At enrollment and at the end of treatment at 6 weeks

Patient Health Questionnaire-9 Screener

Timeframe: At enrollment and at the end of treatment at 6 weeks

Patient Checklist-5

Timeframe: At enrollment and at the end of treatment at 6 weeks

Yale-Brown Obsessive Compulsive Scale

Timeframe: At enrollment and at the end of treatment at 6 weeks

Alcohol Use Disorders Identification Test

Timeframe: At enrollment and at the end of treatment at 6 weeks

National Institute of Drug Abuse Modified Alcohol, Smoking, and Substance Involvement Screening Test

Timeframe: At enrollment and at the end of treatment at 6 weeks